Zantipres Co 30 mg/12,5 mg Film-Coated Tablets

    Zantipres Co 30 mg/12,5 mg Film-Coated Tablets

    S3


    1. What ZANTIPRES CO is and what it is used for

    ZANTIPRES CO contains 30 mg zofenopril calcium and 12,5 mg hydrochlorothiazide as the active ingredients.

    • Zofenopril calcium is a cardiovascular medicine which belongs to a group of blood pressure-lowering medicines called angiotensin-converting enzyme (ACE) inhibitors.
    • Hydrochlorothiazide is a diuretic, that acts by increasing the amount of urine you produce.

    ZANTIPRES CO is used to treat mild to moderate high blood pressure (hypertension), when this is not adequately controlled by taking zofenopril alone.

    2. What you need to know before you take ZANTIPRES CO

    Do not take ZANTIPRES CO:

    • if you are hypersensitive (allergic) to zofenopril, hydrochlorothiazide or any of the other ingredients of ZANTIPRES CO (see section 6)
    • if you are allergic (hypersensitive) to other sulphonamide-derived substances (like hydrochlorothiazide, which is a sulphonamide-derived medicine)
    • if you have had any previous allergic reaction to any other ACE inhibitor, such as captopril or enalapril
    • if you are pregnant or breastfeeding (see Pregnancy and breastfeeding)
    • if you have a history of severe swelling and itching around the face, nose and throat (angioedema) associated with previous ACE inhibitor therapy, or if you suffer from hereditary/idiopathic angioedema (rapid swelling of the skin, tissues, digestive tract and other organs)
    • if you have taken or are currently taking sacubitril/valsartan (a medicine used to treat a type of long-term (chronic) heart failure in adults) as the risk of angioedema (rapid swelling under the skin in an area such as the throat) is increased
    • if you have heart conditions called hypertrophic obstructive cardiomyopathy (abnormally thick heart muscle that can cause shortness of breath, chest pain or abnormal heart rhythms) or aortic stenosis (narrowing of the valve in the large blood vessel of the heart that can cause shortness of breath, chest pain and tiredness)
    • if you suffer from severe liver or kidney problems
    • if you suffer from narrowing of the arteries to the kidneys
    • if you have diabetes or impaired kidney function and you are treated with a blood pressure-lowering medicine containing aliskiren

    Warnings and precautions

    Take special care with ZANTIPRES CO:

    • if you have liver or kidney problems
    • if you have high blood pressure that is caused by a kidney problem or by narrowing of the artery leading to the kidney (renovascular hypertension)
    • if you have recently had a kidney transplant
    • if you are undergoing dialysis
    • if you are on LDL apheresis (a procedure similar to kidney dialysis that clears your blood of harmful cholesterol)
    • if you have abnormally high levels of the hormone aldosterone in your blood (primary aldosteronism)
    • if you have a narrowing of the heart valve (aortic stenosis) or thickening of the heart walls (hypertrophic cardiomyopathy)
    • if you suffer or have suffered from psoriasis (skin disease characterised by scaly pink patches)
    • if you are receiving desensitisation treatment (“allergy injections”) for insect stings
    • if you have lupus erythematosus (a disorder of the immune system, your body’s defence system)
    • if you tend to have low blood potassium, and especially if you suffer from prolonged QT syndrome (a kind of heart problem seen as an ECG abnormality) or you are taking digitalis (to help your heart pump)
    • if you have diabetes
    • if you have angina or disorders affecting the brain, since low blood pressure can lead to a heart attack or stroke
    • if you are taking any of the following medicines used to treat high blood pressure:
    • an angiotensin II receptor blocker (ARBs) (also known as sartans – for example valsartan, telmisartan, irbesartan, etc.), in particular if you have diabetes-related kidney problems
    • aliskiren.

    are taking any of the following medicines, the risk of angioedema (rapid swelling under the skin in area such as the throat) may be increased:

    • racecadotril, a medicine used to treat diarrhoea
    • medicines used to prevent organ transplant rejection and for cancer (e.g., temsirolimus, sirolimus, everolimus)
    • vildagliptin, a medicine used to treat diabetes

    if you have had skin cancer or if you develop an unexpected skin lesion during the treatment. Treatment with hydrochlorothiazide, particularly long-term use with high doses, may increase the risk of some types of skin and lip cancer (non-melanoma skin cancer). Protect your skin from sun exposure and UV rays while taking ZANTIPRES CO.

    if you are elderly or have kidney problems you should not take a fluoroquinolone antibiotic (used to treat bacterial infections) such as moxifloxacin or levofloxacin while taking ZANTIPRES CO as it may cause or aggravate kidney problems. Your doctor may check your kidney function, blood pressure, and the amount of electrolytes (e.g. potassium) in your blood at regular intervals. See Do not take ZANTIPRES CO. The hydrochlorothiazide in ZANTIPRES CO may cause your skin to be oversensitive to sunlight or artificial UV light. Stop taking ZANTIPRES CO and tell your doctor if you get a rash, itchy spots or sensitive skin during treatment (see Possible side effects).

    3. How to take ZANTIPRES CO

    Do not share medicines prescribed for you with any other person. Always take ZANTIPRES CO exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

    Adults (18 to 65 years)

    The recommended dose of ZANTIPRES CO is one tablet per day. ZANTIPRES CO may be taken with food or on an empty stomach. The tablet is best taken with some water. To ease swallowing, you may break the tablet in two and swallow one half right after the other.

    Paediatric population (under 18 years)

    Do not give ZANTIPRES CO to children under the age of 18 years.

    Elderly patients (over 65 years)

    If you are over 65 years and suffer from an impaired kidney function, ZANTIPRES CO may not be suitable for you (see Warnings and precautions). Your doctor will tell you how long your treatment with ZANTIPRES CO will last. Do not stop treatment early. If you have the impression that the effect of ZANTIPRES CO is too strong or too weak, tell your doctor or pharmacist.

    If you take more ZANTIPRES CO than you should:

    In the event of overdosage, consult your doctor or pharmacist. If neither is available, contact the nearest hospital or poison centre. Always take the labelled medicine package with you, whether there are any ZANTIPRES CO tablets left or not. The most frequent symptoms and signs of an overdose are low blood pressure with fainting (hypotension), very slow heart beat (bradycardia), changes in blood chemicals (electrolytes), kidney dysfunction, excessive urination with consequent dehydration, nausea and somnolence, muscle spasms, heart rhythm disturbances (especially if you are also taking digoxin or medicines for heart rhythm problems).

    If you forget to take ZANTIPRES CO:

    If you forgot to take a dose, take it as soon as you remember. However, if your next dose is nearly due, skip the forgotten dose and take the next scheduled normal dose at the usual time. Do not take a double dose to make up for forgotten individual doses.

    If you stop taking ZANTIPRES CO:

    Do not stop taking ZANTIPRES CO unless your doctor tells you to. Should you need to stop taking ZANTIPRES CO, your doctor will decide which is the best method for you. Always consult your doctor before stopping treatment with ZANTIPRES CO.

    4. Possible side effects

    ZANTIPRES CO can have side effects. Not all side effects reported for ZANTIPRES CO are included in this leaflet. Should your general health worsen or if you experience any untoward effects while taking ZANTIPRES CO, please consult your doctor, pharmacist or other healthcare professional for advice.

    If any of the following happens, stop taking ZANTIPRES CO and tell your doctor immediately or go to the casualty department at your nearest hospital:

    • swelling of the hands, feet, ankles, face, lips and mouth or throat, which may cause difficulty in swallowing or breathing
    • rash or itching
    • fainting.

    These are all very serious side effects. If you have them, you may have had a serious reaction to ZANTIPRES CO. You may need urgent medical attention or hospitalisation.

    Tell your doctor if you notice any of the following:

    Frequent side effects:

    • dizziness
    • headache
    • cough.

    Less frequent side effects:

    • infection, bronchitis
    • sore throat
    • increase in blood cholesterol and/or other lipids, increased blood glucose, potassium, uric acid, creatinine and liver enzymes
    • decrease in blood potassium
    • sleeplessness (insomnia) or sleepiness (somnolence), fainting, muscle tightness (hypertonia)
    • angina (chest pain), heart attack, atrial fibrillation, fast irregular heartbeat
    • flushing, low blood pressure, high blood pressure
    • nausea, indigestion (heartburn), gastritis, inflammation of the gums, dry mouth, stomach pain
    • skin disease characterised by scaly pink patches (psoriasis), acne (problem skin), dry skin, itching, hives
    • back pain
    • increased urine (polyuria)
    • general weakness (asthenia), flu-like symptoms, peripheral swelling (usually around the ankles)
    • impotence.

    In addition to the side effects reported with ZANTIPRES CO, the following have generally been reported with ACE inhibitors:

    • Tiredness (fatigue). Severe low blood pressure at the start of treatment or when the dosage is increased, with dizziness, impaired vision, fainting (syncope), low blood pressure on standing.
    • Chest pain, muscle aches and/or cramps.
    • Impaired consciousness, sudden dizziness, suddenly impaired vision or weakness and/or loss of sense of touch on one side of the body (transient ischaemic attack or stroke).
    • Reduced kidney function, changes in the amount of daily urine, presence of proteins in the urine (proteinuria).
    • Vomiting (being sick), nausea (feeling sick), diarrhoea, constipation.
    • Allergic skin reaction with peeling, redness, loosening and blistering of the skin (toxic epidermal necrolysis), worsening of psoriasis, hair loss (alopecia).
    • Increased sweating.
    • Mood changes, depression, sleep disorders.
    • Altered skin sensations such as burning, prickling, or tingling (paraesthesia).
    • Disorders of balance, confusion, ringing in the ears (tinnitus), taste disturbances, blurred vision.
    • Difficulty in breathing, narrowing of the airways in the lung (bronchospasm), sinusitis, runny or stuffy nose (rhinitis), inflammation of the tongue (glossitis).
    • Yellowing of the skin (jaundice), inflammation of the liver or pancreas (hepatitis, pancreatitis), bowel obstruction (ileus).
    • Changes in blood tests, such as red blood cell, white blood cell or platelet count or a reduction in all kinds of blood cells (pancytopenia): Contact your doctor if you find that you bruise easily or develop an unexplained sore throat or fever.
    • Increased blood levels of bilirubin, increased blood urea.
    • Anaemia due to rupture of red blood cells (haemolytic anaemia), which may occur if you suffer from G6PD (glucose 6-phosphate dehydrogenase) deficiency.

    The following side effects were not reported in clinical trials with ZANTIPRES CO, but they have been reported with hydrochlorothiazide, so they may also occur with the use of ZANTIPRES CO:

    • Skin and lip cancer (Non-melanoma skin cancer).
    • Impaired production of new blood cells by the bone marrow (bone marrow failure).
    • Altered levels of body fluids (dehydration) and blood chemicals (electrolytes), gout, diabetes, metabolic alkalosis.
    • Apathy, nervousness, restlessness.
    • Convulsions, depressed level of consciousness, coma, paresis.
    • Yellow vision (xanthopsia), worsening of myopia, decreased lacrimation.
    • Vertigo (spinning sensation).
    • Heart rhythm disturbances (dysrhythmias), changes in the electrocardiogram.
    • Formation of blood clots in veins (thrombosis) and embolism, circulatory collapse (shock).
    • Respiratory distress, lung inflammation (pneumonitis), formation of fibrous tissue in the lungs (interstitial lung disease), fluid accumulation in the lung (pulmonary oedema).
    • Thirst, lack of appetite (anorexia), absence of bowel movements (paralytic ileus), excessive gas in the stomach, inflammation of the glands that produce saliva (sialadenitis), increased blood amylase (a pancreatic enzyme, hyperamylasaemia), inflammation of the gall bladder (cholecystitis).
    • Purple spots/blotches on the skin (purpura), increased sensitivity of your skin to sunlight, rash (especially facial) and/or patchy redness that can cause scarring (cutaneous lupus erythematosus), inflammation of blood vessels with consequent death of tissue (necrotising vasculitis).
    • Acute kidney failure (with reduced urine production and build-up of fluid and waste materials in your body), inflammation of the connective tissue within the kidneys (interstitial nephritis), sugar in the urine.

    If you notice any side effects not mentioned in this leaflet, please inform your doctor or pharmacist.

    Reporting of side effects: If you get side effects, talk to your doctor, pharmacist or nurse. You can also report side effects to SAHPRA via the 6.04 Adverse Drug Reaction Reporting Form, found online under SAHPRA’s publications: https://www.sahpra.org.za/Publications/Index/8. By reporting side effects, you can help provide more information on the safety of ZANTIPRES CO.

    5. How to store ZANTIPRES CO

    • Store at or below 30 °C.
    • Keep blister strips in outer carton until required for use.
    • STORE ALL MEDICINES OUT OF REACH OF CHILDREN.
    • Do not use after the expiry date printed on the carton.
    • Return all unused medicine to your pharmacist.
    • Do not dispose of unused medicine in drains and sewerage systems (e.g. toilets).
    Important Disclaimer

    The Zantipres Co 30 mg/12,5 mg Film-Coated Tablets professional information leaflet below is the property of Lebasi Pharmaceuticals and is provided on Somayeza exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Somayeza serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

    Unlock Exclusive Features

    To ensure the fastest, most secure experience, this feature is exclusively available on the free Somayeza mobile app.

    Download the App to Unlock
    On This Page
    Zantipres Co 30 mg/12,5 mg Film-Coated Tablets
    1/-
    Official PDF leaflet

    The patient information text is available above. Load the original PDF only when you need it.

    Somayeza AI
    Hello! I am your medical reading assistant. What would you like to know about this patient information leaflet?
    Successfully Stashed! 💊

    This patient information leaflet has been safely stored in your digital medical cabinet. No prescription needed to view it later!

    View My Favourites